Predicting carbapenem-resistant Pseudomonas aeruginosa infection risk using XGBoost model and explainability

利用 XGBoost 模型和可解释性预测耐碳青霉烯类铜绿假单胞菌感染风险

阅读:1

Abstract

The prevalence and spread of carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global public health problem. This study aims to identify the risk factors of CRPA infection and construct a machine learning model to provide a prediction tool for clinical prevention and control. A total of 1949 patients with P.aeruginosa health care-associated infections (HAIs) were enrolled in this study. A total of 89 patients with CRPA infection and 89 patients with CSPA infection were matched 1:1. LASSO regression was used to screen the variables, and the XGBoost model was established (136 cases in the training set and 60 cases in the test set). Shapley additive explain (SHAP) method was used to explain the importance of variables. The area under the ROC curve (AUC) and calibration curve were used to evaluate the performance of the model. There were 89 cases of CRPA infection, and the CRPA infection rate was 4.57%. Respiratory tract was the most common source of infection, and ICU and hematology department were the high-risk departments. The AUC value of the XGBoost machine learning model in the training set was 0.987 (95%CI: 0.974-1.000), and the AUC value in the test set was 0.862 (95%CI: 0.750-0.974). The clinical decision curve also showed good results of the model. SHAP results showed that ICU admission, duration of central venous catheterization, use of carbapenems and fluoroquinolones were important factors for predicting CRPA infection. The XGBoost machine learning model is helpful for the early prevention and screening of CRPA infection in medical institutions. Infection control and clinical departments should carry out effective prevention and control for high-risk factors to reduce the occurrence of CRPA infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。